Treatment of lupus psychosis with oral cyclophosphamide followed by azathioprine maintenance: an open-label study

Am J Med. 2003 Jul;115(1):59-62. doi: 10.1016/s0002-9343(03)00135-9.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Administration, Oral
  • Adolescent
  • Adult
  • Anti-Inflammatory Agents / therapeutic use
  • Antibodies, Antinuclear / immunology
  • Azathioprine / administration & dosage
  • Azathioprine / therapeutic use*
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / therapeutic use*
  • Drug Therapy, Combination
  • Drug Tolerance
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Fluorescent Antibody Technique, Indirect
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / therapeutic use*
  • Lupus Erythematosus, Systemic / drug therapy*
  • Lupus Erythematosus, Systemic / immunology
  • Lupus Erythematosus, Systemic / psychology*
  • Male
  • Prednisone / therapeutic use
  • Psychotic Disorders / etiology*

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Antinuclear
  • Immunosuppressive Agents
  • Cyclophosphamide
  • Azathioprine
  • Prednisone